JP2025515337A5 - - Google Patents
Info
- Publication number
- JP2025515337A5 JP2025515337A5 JP2024563361A JP2024563361A JP2025515337A5 JP 2025515337 A5 JP2025515337 A5 JP 2025515337A5 JP 2024563361 A JP2024563361 A JP 2024563361A JP 2024563361 A JP2024563361 A JP 2024563361A JP 2025515337 A5 JP2025515337 A5 JP 2025515337A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- btla
- seq
- variable region
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263335623P | 2022-04-27 | 2022-04-27 | |
| US63/335,623 | 2022-04-27 | ||
| PCT/US2023/066258 WO2023212611A1 (en) | 2022-04-27 | 2023-04-26 | B and t lymphocyte attenuator (btla) modulators and method of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515337A JP2025515337A (ja) | 2025-05-14 |
| JP2025515337A5 true JP2025515337A5 (enExample) | 2026-05-11 |
Family
ID=86558778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563361A Pending JP2025515337A (ja) | 2022-04-27 | 2023-04-26 | Ｂ及びｔリンパ球アテニュエータ（ｂｔｌａ）調節因子及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250282872A1 (enExample) |
| EP (1) | EP4514850A1 (enExample) |
| JP (1) | JP2025515337A (enExample) |
| KR (1) | KR20250007603A (enExample) |
| AU (1) | AU2023259623A1 (enExample) |
| CA (1) | CA3256715A1 (enExample) |
| IL (1) | IL316496A (enExample) |
| MX (1) | MX2024013146A (enExample) |
| WO (1) | WO2023212611A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023004633A (es) * | 2020-10-23 | 2023-05-12 | Anaptysbio Inc | Moduladores del atenuador de linfocitos b y t (btla) y metodo de uso de los mismos. |
| WO2024243594A1 (en) * | 2023-05-25 | 2024-11-28 | Anaptysbio, Inc. | Btla agonist for mudulation of dendritic cells |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4828981A (en) | 1983-08-24 | 1989-05-09 | Synbiotics Corporation | Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| ATE159548T1 (de) | 1990-11-13 | 1997-11-15 | Immunex Corp | Bifunktionelle wählbare fusionsgene |
| AU6953394A (en) | 1993-05-21 | 1994-12-20 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| US5464758A (en) | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| FR2814642B1 (fr) | 2000-10-03 | 2005-07-01 | Ass Pour Le Dev De La Rech En | Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee |
| US7771951B2 (en) | 2001-12-03 | 2010-08-10 | Amgen Fremont Inc. | Antibody categorization based on binding characteristics |
| JP5675109B2 (ja) | 2007-02-20 | 2015-02-25 | アナプティスバイオ インコーポレイティッド | ライブラリーの生成方法及びその使用 |
| CA2769473A1 (en) * | 2009-07-31 | 2011-02-03 | N.V. Organon | Fully human antibodies to btla |
| MX2023004633A (es) * | 2020-10-23 | 2023-05-12 | Anaptysbio Inc | Moduladores del atenuador de linfocitos b y t (btla) y metodo de uso de los mismos. |
-
2023
- 2023-04-26 AU AU2023259623A patent/AU2023259623A1/en active Pending
- 2023-04-26 US US18/859,958 patent/US20250282872A1/en active Pending
- 2023-04-26 WO PCT/US2023/066258 patent/WO2023212611A1/en not_active Ceased
- 2023-04-26 EP EP23726259.7A patent/EP4514850A1/en active Pending
- 2023-04-26 IL IL316496A patent/IL316496A/en unknown
- 2023-04-26 JP JP2024563361A patent/JP2025515337A/ja active Pending
- 2023-04-26 KR KR1020247039407A patent/KR20250007603A/ko active Pending
- 2023-04-26 CA CA3256715A patent/CA3256715A1/en active Pending
-
2024
- 2024-10-24 MX MX2024013146A patent/MX2024013146A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024069453A5 (enExample) | ||
| US11993605B2 (en) | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof | |
| US20210221882A1 (en) | Uses of a dual v region antibody-like protein | |
| CN104829718A (zh) | 前列腺素e2结合蛋白及其用途 | |
| RU2015114923A (ru) | СПОСОБЫ ЛЕЧЕНИЯ IL-1β-ЗАВИСИМЫХ ЗАБОЛЕВАНИЙ | |
| RU2697383C2 (ru) | Применение антагонистов il-17 для торможения прогрессирования структурных повреждений у пациентов с псориатическим артритом | |
| CN103172739A (zh) | Il-12/p40结合蛋白 | |
| TW202318436A (zh) | 用於預測細胞激素釋放症候群之多變量模型 | |
| IL310216A (en) | Methods of treating crohn's disease with anti-il23 specific antibody | |
| JP2021515770A5 (enExample) | ||
| JP2022529929A5 (enExample) | ||
| JP2021523138A5 (enExample) | ||
| Zhang et al. | High-throughput single-cell analysis reveals Omp38-specific monoclonal antibodies that protect against Acinetobacter baumannii infection | |
| JP2022534794A5 (enExample) | ||
| JP2022514561A5 (enExample) | ||
| JP2023546713A5 (enExample) | ||
| JP2023527200A5 (enExample) | ||
| JP2023527059A5 (enExample) | ||
| JP2024542777A5 (enExample) | ||
| JP2023544620A5 (enExample) | ||
| JP2023514567A5 (enExample) | ||
| EP4188440A2 (en) | Cd-3 antibodies for the treatment of coronavirus | |
| JP2023506779A5 (enExample) | ||
| JP2018534915A5 (enExample) | ||
| JP2024095754A (ja) | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |